Holen Sie sich die Stockscreener-App
83.70
1.22%
0.725
Schlusskurs vom Vortag:
$82.98
Offen:
$82.57
24-Stunden-Volumen:
495.14K
Relative Volume:
0.61
Marktkapitalisierung:
$8.80B
Einnahmen:
$628.56M
Nettoeinkommen (Verlust:
$141.82M
KGV:
66.43
EPS:
1.26
Netto-Cashflow:
$142.60M
1W Leistung:
+4.00%
1M Leistung:
+13.93%
6M Leistung:
+19.02%
1J Leistung:
+41.73%
1-Tages-Spanne:
$81.31
$84.92
1-Wochen-Bereich:
$80.83
$87.19
52-Wochen-Spanne:
$49.00
$117.33
Corcept Therapeutics Inc Stock (CORT) Company Profile
Firmenname
Corcept Therapeutics Inc
Sektor
Branche
Telefon
650.688.8803
Adresse
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Vergleichen Sie CORT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CORT
Corcept Therapeutics Inc
|
83.70 | 8.73B | 628.56M | 141.82M | 142.60M | 1.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.92 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
699.15 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
418.13 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
893.47 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.88 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-11-06 | Hochstufung | Truist | Hold → Buy |
| 2023-04-11 | Eingeleitet | SVB Securities | Market Perform |
| 2023-04-04 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-15 | Herabstufung | Jefferies | Buy → Hold |
| 2022-08-01 | Herabstufung | Truist | Buy → Hold |
| 2022-07-27 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-27 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-02-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-01-28 | Eingeleitet | Truist | Buy |
| 2020-08-05 | Herabstufung | Jefferies | Buy → Hold |
| 2019-09-24 | Eingeleitet | Jefferies | Buy |
| 2019-09-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-02-04 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2018-08-10 | Bestätigt | Stifel | Hold |
| 2018-05-31 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-09 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-08-31 | Eingeleitet | Stifel | Buy |
| 2017-02-02 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2015-04-21 | Eingeleitet | FBR Capital | Outperform |
| 2014-01-13 | Herabstufung | Stifel | Buy → Hold |
| 2013-08-09 | Herabstufung | Janney | Buy → Neutral |
| 2013-08-09 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2012-02-21 | Bestätigt | JMP Securities | Mkt Outperform |
| 2010-01-06 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2008-07-17 | Eingeleitet | Rodman & Renshaw | Mkt Outperform |
| 2007-06-21 | Hochstufung | Punk, Ziegel & Co | Mkt Perform → Accumulate |
Alle ansehen
Corcept Therapeutics Inc Aktie (CORT) Neueste Nachrichten
Hsbc Holdings PLC Reduces Stock Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics Incorporated $CORT Shares Sold by American Century Companies Inc. - MarketBeat
Epoch Investment Partners Inc. Invests $56.18 Million in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept, Optime file reply for dismissing Teva's US antitrust claims - MLex
Kennedy Capital Management LLC Raises Stake in Corcept Therapeutics Incorporated $CORT - MarketBeat
Norges Bank Makes New Investment in Corcept Therapeutics Incorporated $CORT - MarketBeat
State Board of Administration of Florida Retirement System Has $4.30 Million Stock Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
Is Corcept Therapeutics Incorporated (HTD) stock a buy before new product rolloutEarnings Performance Report & Weekly High Return Stock Forecasts - Newser
Insider Selling: Corcept Therapeutics (NASDAQ:CORT) Insider Sells 20,000 Shares of Stock - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) Insider Sean Maduck Sells 20,000 Shares - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) Insider Sells $397,650.00 in Stock - MarketBeat
Will Corcept Therapeutics Incorporated (HTD) stock return to pre crash levelsMarket Volume Report & Free High Accuracy Swing Entry Alerts - Newser
Corcept (CORT) Up 9.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Chief Development Officer At Corcept Therapeutics Sells $364K Of Stock - Benzinga
Is Corcept Therapeutics Incorporated (HTD) stock inflation resilient2025 Momentum Check & Fast Moving Stock Trade Plans - Newser
Shelton Capital Management Sells 125,365 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Bridge City Capital LLC Sells 22,487 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics Insider Sold Shares Worth $1,590,490, According to a Recent SEC Filing - marketscreener.com
Corcept Therapeutics Insider Sold Shares Worth $3,190,796, According to a Recent SEC Filing - MarketScreener
Lyon of Corcept Therapeutics sells $397k in shares By Investing.com - Investing.com South Africa
Corcept Therapeutics exec William Guyer sells $1.6m in shares By Investing.com - Investing.com Canada
Officer Guyer Sells 20,000 ($1.6M) Of Corcept Therapeutics Inc [CORT] - TradingView
Lyon of Corcept Therapeutics sells $397k in shares - Investing.com
Corcept Therapeutics CEO Belanoff sells $3.19 million in stock By Investing.com - Investing.com Canada
Van Hulzen Asset Management LLC Purchases New Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
3 Growth Companies With High Insider Ownership Seeing 30% Revenue Growth - simplywall.st
Russell Investments Group Ltd. Has $13.67 Million Stake in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics Incorporated $CORT Shares Sold by SG Americas Securities LLC - MarketBeat
Officer Guyer Files To Sell 20,000 Of Corcept Therapeutics Inc [CORT] - TradingView
Corcept Therapeutics (CORT) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Will Corcept Therapeutics Incorporated (HTD) stock outperform global peers - Newser
Is Corcept Therapeutics Incorporated (HTD) stock undervalued at current priceMarket Risk Analysis & Low Risk Investment Opportunities - Newser
Will Korlym Continue to Drive Corcept's Top Line in 2026? - Yahoo Finance
Corcept Therapeutics Incorporated $CORT Shares Sold by Rhumbline Advisers - MarketBeat
F m Investments LLC Invests $1.61 Million in Corcept Therapeutics Incorporated $CORT - MarketBeat
Capital Fund Management S.A. Trims Stock Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
19,858 Shares in Corcept Therapeutics Incorporated $CORT Acquired by XTX Topco Ltd - MarketBeat
Cushing’s Syndrome Diagnostics and Therapeutics Market, 2034 - Global Market Insights Inc.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Is Largely Controlled by Institutional Shareholders Who Own 69% of the Company - 富途牛牛
Legal & General Group Plc Boosts Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
Zacks Research Analysts Decrease Earnings Estimates for CORT - MarketBeat
Franklin Resources Inc. Increases Stock Position in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept (CORT) Q3 2025 Earnings Call Transcript - The Globe and Mail
Corcept Therapeutics (NASDAQ:CORT) Insider Sells $364,050.00 in Stock - MarketBeat
Whale Trades: Will Corcept Therapeutics Incorporated stock deliver strong dividend growthJuly 2025 Chart Watch & Expert Approved Trade Ideas - moha.gov.vn
Chief Development Officer Of Corcept Therapeutics Sold $364K In Stock - Benzinga
What is Zacks Research's Forecast for CORT FY2025 Earnings? - MarketBeat
Corcept Therapeutics Incorporat (CORT) Stock Forecasts - Yahoo Finance
Aug PreEarnings: Can Corcept Therapeutics Incorporated stock sustain free cash flow growth2025 Breakouts & Breakdowns & AI Powered Trade Plan Recommendations - BỘ NỘI VỤ
Insider Sell: William Guyer Sells Shares of Corcept Therapeutics Inc (CORT) - GuruFocus
CORCEPT THERAPEUTICS' Chief Development Officer Sells Shares - TradingView
Finanzdaten der Corcept Therapeutics Inc-Aktie (CORT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):